NCT05244915

Brief Summary

This project assesses the feasibility of utilizing the geriatric assessment as a tool to identify distressed older caregivers of older adults with cancer. The investigator will engage key stakeholders including older caregivers of older adults with cancer, experts in geriatric oncology and primary care physicians to develop and pilot a supportive care intervention to improve outcomes in older caregivers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

December 7, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2023

Completed
Last Updated

January 6, 2025

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

August 3, 2021

Last Update Submit

January 3, 2025

Conditions

Keywords

CancerGeriatric Assessment

Outcome Measures

Primary Outcomes (3)

  • Percentage of participants who enroll and complete the GA

    Percentage of participants who were approached, enrolled in the study and completed the GA will be determined.

    8 weeks per participant

  • Time for caregivers to complete the GA

    Time to complete the GA per caregiver will be determined by summing the time to complete self-administered and clinic portions of GA.

    8 weeks per patient

  • Caregiver satisfaction with completing the GA

    Caregivers will complete a questionnaire to assess satisfaction with completing the GA

    8 weeks per patient

Secondary Outcomes (1)

  • Percentage of caregiver supportive care recommendations that are implemented by patient/caregiver physicians

    4 weeks

Study Arms (1)

Experimental

EXPERIMENTAL

Participants will receive a geriatric assessment which consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on participant responses, tailored recommendations will be provided.

Other: Experimental (Delphi Surveys)Other: Experimental (Focus Groups)Other: Qualitative interviews

Interventions

The Delphi method, a process used to arrive at a group opinion or decision by surveying a panel of experts, will be used with experts in geriatric oncology to develop a supportive care management intervention for older caregivers of older adults with cancer.

Experimental

Focus group qualitative interviews will be conducted with key stakeholders consisting of older adults with cancer and their caregivers.

Experimental

Qualitative interviews will be conducted with older caregivers of older adults with cancer to inquire about their experience with caregiving and unmet supportive care needs.

Experimental

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patient and caregiver be aged 65 or older
  • Patient with a diagnosis of solid tumor malignancy or lymphoma, any stage
  • Patients who have initiated a new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy) OR are being considered for new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy).
  • Patients and caregivers must be able to provide informed consent, or if it is determined that they do not have decision-making capacity, a patient-designated health care proxy must sign consent per institutional University of Rochester and Research Subject Review Board policies on consent for incapacitated/decisionally impaired subjects.

You may not qualify if:

  • Patient or caregiver is less than 65 years of age
  • Patient and caregivers who do not have decision-making capacity (decisionally or cognitively impaired) AND do NOT have a previously designated health care proxy available to sign consent.
  • Caregivers enrolled in phase I
  • Patient and caregiver have completed a GA
  • Patient and caregiver have not completed a GA
  • Member of SCOREboard Community Advisory Board
  • Aged 65 years or older
  • Has been a family member, partner, friend or caregiver to an older adult with cancer
  • Members of the Cancer and Aging Research Group
  • Primary care physicians who care for older adults
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Focus Groups

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Sindhuja Kadambi

    Univ. of Rochester Wilmot Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Instructor - Department of Medicine , Hematology/Oncology (SMD)

Study Record Dates

First Submitted

August 3, 2021

First Posted

February 17, 2022

Study Start

December 7, 2021

Primary Completion

August 11, 2023

Study Completion

August 11, 2023

Last Updated

January 6, 2025

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

A complete and final study protocol will be made publicly available through the University of Rochester Cancer Center Community Oncology Research Program Research Base Protocol and Data Sharing Committee. The full protocol and data will be made publicly available no later than the publication date of the study findings from the final dataset. The protocol will include a detailed description of the study population, hypotheses tested, measurement and assessment information, data definitions and codes, and the analysis plan utilized. We will be collecting identifying information. The final dataset will be stripped of identifiers prior to release for sharing. Published papers will be made available in portable document format.

Time Frame
The data will be available for 7 years from accrual of the first subject.

Locations